| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $7.80K | $6.30K | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $145.10K | $27.57K | $48.05K | $28.49K | $731.00 |
| R&D | – | – | – | – | – |
| SG&A | $145.10K | $27.57K | $48.05K | $28.49K | $731.00 |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$145.10K | -$27.57K | -$40.25K | -$22.19K | -$731.00 |
| EPS (basic) | 0.0000 | 0.0000 | 0.0000 | -0.0100 | 0.0000 |
| EPS (diluted) | 0.0000 | 0.0000 | 0.0000 | -0.0100 | 0.0000 |
| Shares (diluted) | $3.63M | $3.63M | $3.62M | $2.88M | $2.50M |